Q&A: Alzheimer’s research ‘laying the foundation for precision medicine’

The Alzheimer’s Association International Conference 2026 will meet in London, with breakthrough research planned across workshops, lectures and plenary sessions. Laura Nisenbaum, PhD, interim chief science officer of the Alzheimer’s Drug Discovery Foundation, will be at the event, which runs from July 12 to July 15. Healio spoke with her about what she’s looking forward

Raccontata dahealio.com